Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta
Chiang, Eddie T.
Kelly, Gabriel T.
Singleton, Patrick A.
Camp, Sara M.
Dudek, Steven M.
Black, Steven M.
Garcia, Joe G. N.
Jacobson, Jeffrey R.
AffiliationUniv Arizona, Dept Med
Univ Arizona, Arizona Resp Ctr
MetadataShow full item record
PublisherPublic Library of Science
CitationXie L, Chiang ET, Wu X, Kelly GT, Kanteti P, Singleton PA, et al. (2016) Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta. PLoS ONE 11(7): e0158865. doi:10.1371/journal.pone.0158865
Rights© 2016 Xie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractProtein Kinase C (PKC) plays a significant role in thrombin-induced loss of endothelial cell (EC) barrier integrity; however, the existence of more than 10 isozymes of PKC and tissue-specific isoform expression has limited our understanding of this important second messenger in vascular homeostasis. In this study, we show that PKC delta isoform promotes thrombin-induced loss of human pulmonary artery EC barrier integrity, findings substantiated by PKC delta inhibitory studies (rottlerin), dominant negative PKC delta construct and PKC delta silencing (siRNA). In addition, we identified PKC delta as a signaling mediator upstream of both thrombin-induced MLC phosphorylation and Rho GTPase activation affecting stress fiber formation, cell contraction and loss of EC barrier integrity. Our inhibitor-based studies indicate that thrombin-induced PKC delta activation exerts a positive feedback on Rho GTPase activation and contributes to Rac1 GTPase inhibition. Moreover, PKD (or PKC mu) and CPI-17, two known PKC delta targets, were found to be activated by PKC delta in EC and served as modulators of cytoskeleton rearrangement. These studies clarify the role of PKC delta in EC cytoskeleton regulation, and highlight PKC delta as a therapeutic target in inflammatory lung disorders, characterized by the loss of barrier integrity, such as acute lung injury and sepsis.
VersionFinal published version
SponsorsNational Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI) [P01HL58064, R01HL91889, P01HL98050, R01HL96887, T32HL007249]
- PKCdelta mediates thrombin-augmented fibroblast-mediated collagen gel contraction.
- Authors: Fang Q, Mao L, Kobayashi T, Wang X, Wyatt TA, Kim H, Liu X, Rennard SI
- Issue date: 2008 May 16
- PKCdelta regulates endothelial basal barrier function through modulation of RhoA GTPase activity.
- Authors: Harrington EO, Shannon CJ, Morin N, Rowlett H, Murphy C, Lu Q
- Issue date: 2005 Aug 15
- Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction.
- Authors: Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JG, Verin AD
- Issue date: 2004 Jan
- Thrombin stimulates stress fiber assembly in RPE cells by PKC/CPI-17-mediated MLCP inactivation.
- Authors: Ruiz-Loredo AY, López E, López-Colomé AM
- Issue date: 2012 Mar
- Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway.
- Authors: Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A
- Issue date: 2004 Apr 9